You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 16 Next »

Late Gadolinium Enhancement (LGE) is an assessment made with CMR imaging that includesr gadolinium contrast administration. The test is done to assess for gadolinium contrast material accumulation in the tissue with increased extracellular space to determine both left and right ventricle fibrosis (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801263/). For LGE, the assessment relates to the timing of the reading showing whether or not the contrast is present or not at the specific time of the reading (would be determined by the protocol but typically is noted approximately 10 minutes after contrast injection). If the LGE is noted as present, more assessments may be done such as presence per segment and the percentage of presence per segment.

  1. Is "CARDIAC WALL" okay for location?  
    1. It is the only term in CT that fits.  It seems wrong because technically if there is a mass within the heart, it would be seen on the CMR imaging.
  2. All the segments in the CT is for the LV, is it safe to assume the same segments for RV?
  3. Request SME review and update of text and values.

Note from standards discussion - Determined this would be an indicator test and there is an additional term LGE percentage. → is there anything different to do with this?

The Procedures (PR) dataset is an interventions domain that represents diagnostic, preventive, and therapeutic activity. The PR dataset shows the cardiac magnetic resonance imaging with two different MR machines.

Row 1:Shows a cardiac MRI for subject 201.
Row 2:Shows a cardiac MRI for subject 202 with a different MRI machine.

pr.xpt

pr.xpt

Row

STUDYID

DOMAIN

USUBJID

SPDEVID

PRSEQ

PRREFID

PRLNKID

PRTRT

PRLOC

PRFAST

PRSTDTC

1

DMD-LGE

PR

201

ABC001

1

12345678

04

CARDIAC MAGNETIC RESONANCE IMAGING

CARDIAC WALL

Y

2023-07-01T08:55:00

2

DMD-LGE

PR

202

ABC002

2

98765432

05

CARDIAC MAGNETIC RESONANCE IMAGING

CARDIAC WALL

N

2020-07-02T10:05:00

$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

The Cardiovascular System Findings (CV) dataset contains physiological and morphological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels. The findings from the CMR procedure for LGE are noted in this example.
Rows 1-5:Show the late gadolinium enhancement (LGE) is present and affecting 4 segments with corresponding percentage for each segment for subject 201.
Row 6:Shows the late gadolinium enhancement (LGE) is absent for subject 202.

cv.xpt

cv.xpt

Row

STUDYID

DOMAIN

USUBJID

CVSEQ

CVLNKID

CVTESTCD

CVTEST

CVORRES

CVORRESU

CVSTRESC

CVSTRESN

CVSTRESU

CVLOC

CVMETHOD

VISITNUM

VISIT

CVDTC

1DMD-LGECV201104
LATE GADOLINIUM ENHANCEMENT

PRESENT


PRESENT




CARDIAC MAGNETIC RESONANCE IMAGING1SCREENING2023-07-01
2DMD-LGECV201204
LATE GADOLINIUM ENHANCEMENT (# of segments)

4


4

4

CARDIAC MAGNETIC RESONANCE IMAGING1SCREENING2023-07-01
3DMD-LGECV201304LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

20

%

20

20%

LEFT VENTRICULAR BASAL ANTERIOR SEGMENT

CARDIAC MAGNETIC RESONANCE IMAGING1SCREENING2023-07-01
4DMD-LGECV201404LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

30

%

30

30%LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING1SCREENING2023-07-01
5DMD-LGECV201504LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

45

%

45

45%LEFT VENTRICULAR MID INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING1SCREENING2023-07-01
5DMD-LGECV201604LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

50

%

50

50%RIGHT VENTRICULAR MID INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGING1SCREENING2023-07-01
1DMD-LGECV202105
LATE GADOLINIUM ENHANCEMENT

ABSENT


ABSENT




CARDIAC MAGNETIC RESONANCE IMAGING1SCREENING2023-07-01
$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

The Procedure Agent (AG) dataset is an interventions domain that contains the agents administered to the subject as part of a procedure or assessment. The AG dataset shows the timing of the Gadolinium based contrast, GD-DOTA. 

ag.xpt

ag.xpt

Row

STUDYID

DOMAIN

USUBJID

AGSEQ

AGLNKID

AGTRT

AGCAT

AGDOSE

AGDOSU

AGDOSFRM

AGROUTE

AGSTDTC

1

DMD-LGE

AG

201

1

04

Gd-DOTA

CONTRAST AGENT

8

mL

SOLUTION

INTRAVENOUS

2023-07-01T08:45:00

1

DMD-LGE

AG

202

1

05

Gd-DOTA

CONTRAST AGENT

10

mL

SOLUTION

INTRAVENOUS

2023-07-05T09:55:00

$warningHtml

  • No labels